Keeping Up With Cardiovascular Therapies
Current applications and future directions of medical simulation in cardiovascular medicine.
The field of interventional cardiovascular medicine is a dynamic, rapidly expanding discipline that demands technical excellence by its practitioners. There is an ever-increasing number of technologies being applied to different areas of the cardiovascular system. This rapid expansion of minimally invasive therapies requires the concomitant development of effective methods to educate physicians in optimal applications and techniques. To this end, we have established The Interventional Cardiovascular Training Center in Philadelphia to (1) train physician operators in new and emerging technologies, (2) partner with industry to develop, refine, and test new interventional tools, and (3) train nurses and technologists in optimal application of new cardiovascular procedures.
The Center has developed an integrated approach to education using the case method of teaching. Three types of educational tools are utilized in concert: medical simulation, live-case demonstrations, and focused state-of-the-science reviews related to specific clinical case scenarios. Educational formats include (1) small group (6 to 12 physician participants) programs dedicated to specific topics (eg, carotid stenting), (2) preceptorships in which individuals devote block time to master new techniques, (3) larger training courses involving 150 to 200 attendees, such as The first Fellows Global Interventional Cardiovascular program occurring in December 2005 in Philadelphia, cosponsored by the Society of Cardiovascular Angiography and Intervention, and (4) presentation at large interventional meetings (eg, TCT and Euro PCR).
ROLE OF SIMULATION
We have used a sophisticated medical simulation system as a key component in cardiovascular training. The simulator encourages the trainee to accelerate his or her learning curve because interactivity is a hallmark of this educational technique. Interactivity is associated with a higher level of learning achievement and retention of knowledge
(Figure 1).2 Furthermore, interaction improves learning performance because it encourages elaborative processing of information. We have used the simulator as a substitute for live-case demonstrations in the following format: a complex case is presented by a “talking head” that appears on the screen and the history, physical examination and noninvasive data, and angiographic findings are presented. A featured guest operator (an acknowledged expert) is then invited to perform the procedure. The cases are written so that multiple branch points are encountered and choices are available to the operator, with different clinical consequences resulting from proper or incorrect choices. Large video screens showing the simulated cinefluoroscopic images, hemodynamics, and EKG displays are visible to the audience. The moderators can interrupt the action at any branch point and query the attendees using an audience response system, encouraging maximum interactivity. A separate screen displays the scientific bases for various therapeutic strategies.
The operator must demonstrate requisite skills in interpreting clinical data and in performance of the procedure. The operator must select optimal angiographic views and interventional equipment, perform with technical dexterity, and utilize adjunctive pharmacology appropriately.
There are unique advantages of simulated live cases over the traditional live-case method. For example, complications can be programmed that require skilled operator response. These complications may be infrequently encountered in traditional live cases. The trainee can observe the reasoning of an acknowledged expert as he or she works through a difficult problem or serious adverse event; when a complication occurs in a “real” live case, the transmission is often switched (for understandable reasons) to a smoothly running case. A very large library of cases can be developed with specific teaching points for each case. Furthermore, cases that do not lend themselves to the traditional live-case format can be demonstrated. For example, acute myocardial infarction intervention is often excluded from traditional live-case demonstrations. We have utilized this method of teaching for complex coronary interventions, carotid stenting with distal neuroprotection, and interventional therapy for structural heart disease (Table 1).
We have also used the simulator as an individual training tool in which the trainee works through the clinical case scenario during a course. For example, during a program in carotid angiography and stenting, the trainee must first understand proper patient selection, interpret noninvasive testing, and perform four-vessel angiography correctly. Second, the operator must learn interventional equipment selection and proper use of embolic protection devices. The trainee should master techniques of dealing with different aortic arches and must deal with varying lesion complexities and understand the intricacies of adverse event management.
Because the simulator can track variables such as procedural complications, correct/incorrect selection of treatment strategies, and equipment and fluoroscopic time, a score can be generated that may be compared to a group of expert operators for that procedure. These data can be used to direct trainees toward areas of weakness and to improve their skills. Furthermore, the quantitative information generated during these exercises may be used in the future as a testing component during certification examinations and quality assurance initiatives.
CARDIOVASCULAR PROCEDURES IN WHICH SIMULATION WILL PLAY A MAJOR ROLE
Complex Coronary Artery Disease
With the advent of drug-eluting stents,2 proper patient selection and advanced levels of technical expertise are increasingly important. Patient and lesion subsets, which were previously in the realm of the surgeon, are now being referred for percutaneous intervention. Safe performance of these procedures will require advanced simulation training in techniques such as left main stenting, bifurcation stenting, use of distal protection devices, and rotational atherectomy.
Peripheral Vascular, Renal, and Brachiocephalic Disease
As interventional cardiologists, vascular surgeons, and interventional radiologists move to perform peripheral interventions, simulation for aortoiliac, renal, and brachiocephalic disease should play an important role in training and certification for these indications (Figure 2).
Carotid Stenting With Neuroprotection
There are an estimated 250,000 patients in the US at risk for cerebrovascular accident due to carotid disease.3 Training for interventional cardiologists, radiologists, and vascular surgeons will be in great demand because recent data from randomized trials have shown a benefit from carotid stent placement compared with carotid endarterectomy.4 Stent manufacturers require completion of carotid simulation procedures as a prerequisite to approval for use of their products in patients. Medical Simulation Corporation (Englewood, CO) has developed a 2-day, small group (six physicians) carotid training program implementing live-case observation, didactic presentations and simulation, coauthored by Michael Jaff, DO, and Dan McCormick, MD. More than 170 physicians have attended the carotid simulation training courses at 15 leading medical centers across the US (Table 2), starting at Hahnemann University Hospital in Philadelphia in March 2004. There is also a need to incorporate new technologies into the armamentarium of operators performing these procedures. New filters, balloon occlusion devices, proximal protection systems, newer-generation stents, and delivery systems will need to be tested and taught on simulators (Figure 3).
Atrial septal defects and patent foramen ovale are a class of atrial septal structural defects that may cause paradoxical embolism and heart failure. These defects, also previously in the purview of the cardiac surgeon, are increasingly being referred for percutaneous intervention.5 These techniques require a profound understanding of indication, three-dimensional structural heart anatomy, and interpretation of online ultrasound images via transesophageal echocardiography and/or intracardiac echocardiography (Figure 4).
Furthermore, a plethora of new devices are being developed for closure of atrial and patent foramen ovale defects, each with specific technical steps. These steps can be mastered with simulation.
Long relegated to a role as minor niche diagnostic procedure, the importance of transseptal puncture has re-emerged with the advent of techniques such as left atrial appendage exclusion, biventricular pacing, and percutaneous mitral valvuloplasty. Simulation lends itself particularly well for training in these procedures.
Left Atrial Appendage Exclusion
The recognition that approximately 85% of thrombi that embolize as a result of atrial fibrillation originate from the left atrial appendage (LAA) has given impetus to the development of LAA exclusion.6 Given the frequent incidence of atrial fibrillation along with the complications associated with warfarin therapy, this technology may have an enormous impact in cardiovascular therapeutics. LAA exclusion is technically demanding, requiring training in transseptal puncture, interpretation and utilization of transesophageal echocardiography images, and proper device sizing and placement. For the first time, simulation is being used for training operators in a clinical trial investigating the efficacy of a new LAA exclusion device.
Percutaneous Valve Intervention
In no other area of interventional cardiology is the value of medical simulation more important than in the burgeoning area of percutaneous valve management.7 The complex array of underlying pathologic mechanisms in the large constellation of valve disorders has challenged device manufacturers to produce an even more complex assortment of unique tools. New technical skills will need to be mastered. The spectrum of regurgitant mitral valve disorders has its origins in a variety of underlying pathophysiologic mechanisms from degenerative changes to annular dilatation to prolapse and papillary muscle dysfunction. Each pathologic mechanism is finding itself host to new, highly specialized, and vastly different interventional solutions. Proposed treatments might involve placement of various restraining devices in the coronary sinus to extrinsically shrink the mitral annulus. Suture- and clip-based methodologies to work directly on mitral leaflets are being explored. Positioning systems using magnets may be involved to facilitate placement of the above leaflet restraints. The required technical skills will be vastly different from those in current practice, requiring far more sophisticated interventional skills.
Percutaneous replacement of stenotic aortic valves is emerging as well. Proposed solutions and unique strategies are expanding continually. An array of balloon-expandable valves will compete with self-expanding technologies. Transapical, transseptal/antegrade, and retrograde solutions are all in development. Each will require very specific critical and very specific deployment strategies. Proper selection of devices will pose its own set of challenges.
Careful device selection will eventually require a knowledge base that in itself has yet to be defined. The classic proctor-facilitated watch-one/do-one approach to interventional training will be inadequate. The medical simulation environment with three-dimensional “real-time” challenges presenting operators with all of the complexities involved will be indispensable. In addition, there will be great challenges in the maintenance of unique and infrequently used skill sets, which are critical for specific devices. As in the airline industry, attainment and skill maintenance can be achieved with simulation.
Thoracic and Abdominal Aortic Endovascular Repair
There are rapidly developing technologies for the endovascular treatment of aortic aneurysmal disease, and it has been estimated that 35% of all AAAs are treated by a minimally invasive approach.8 With the expanding application of this technology to ruptured AAAs, complex aortic anatomy, and the need for repeat interventions, secondary procedures, and the management of endoleaks, advanced technical skills will need to be developed. However, these programs are difficult to access because of limited training and access to operating suites.
The recent release of an FDA-approved device for the treatment of thoracic aortic aneurysms will require the acquisition of catheter skills, as well as recognition of endovascular approaches to acute and chronic thoracic aortic dissection, and the limitations and complications of treatment in this area.
Simulation training programs are being developed that will provide broader access to structured and reproducible training and more comprehensive exposure to the broad repertoire of catheter skills required to master this expanding field of endovascular medicine. This approach eliminates the need for animal/cadaver lab training and allows physicians to experience important rare procedural adverse events and complications without patient risk.
SUMMARY AND CONCLUSIONS
Given the array of new techniques available for treating cardiac and vascular disease, simulation is a powerful tool that can provide unique educational and training opportunities. We believe that simulation should be a required component for all new procedural training. The educational formats include substitution of simulation cases for traditional live cases as well as the use of simulators to train and test the competence of individual operators.
The goal of simulation should be to enhance education by providing exposure to new technologies, teach effective methods to prevent and deal with complications, and improve medical care without risk to patients.
Jahan Zeb, MD, is an interventional cardiology fellow with Hahnemann University Hospital, Philadelphia, Pennsylvania. He has disclosed that he holds no financial relationship with any of the companies mentioned herein. Dr. Zeb may be reached at (215) 205-8795; email@example.com.
Daniel McCormick, DO, is the Director of the Cardiac Catheterization Laboratory at Hahnemann University Hospital, Philadelphia, Pennsylvania. He has disclosed that he is a paid consultant for Medical Simulation Corporation. Dr. McCormick may be reached at (215) 762-2270; Daniel.McCormick@tenethealth.com.
Daniel Dadourian, MD, is an interventional cardiologist with Hahnemann University Hospital, Philadelphia, Pennsylvania. He has disclosed that he holds no financial relationship with any of the companies mentioned herein. He may be reached at (215) 762-2270.
Sheldon Goldberg, MD, is Professor of Medicine at Drexel University College of Medicine, and Director of Interventional Cardiology with Hahnemann University Hospital, Philadelphia, Pennsylvania. He has disclosed that he is a paid consultant for Medical Simulation Corporation. Dr. Goldberg may be reached at (215) 762-1709; firstname.lastname@example.org.
The authors would like to acknowledge the expert secretarial assistance of Ms. Dee Contreras in the preparation of this manuscript.
1. Najjar L. Principles of educational multimedia user interface design. Human Factors. 1998;40:311-323.
2. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003; 349:1315–1323.
3. Heart and stroke facts. Dallas: American Heart Association, 1991.
4. Yadav J, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351:1493-1501.
5. Windecker S, Wahl A, Nedeltchev K, et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. JACC. 2004;44:750-758.
6. Nakai T, Lesh MD, Gerstenfeld EP, et al. Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism. Circulation. 2002;105:2217.
7. Vahanian A, et al. Percutaneous approaches to valvular disease. Circulation. 2004;109:1572-1579.
8. Katzen, Drake BD, MacLean AA, et al. Endovascular repair of abdominal and thoracic aortic aneurysms. Circulation. 2005;112:1663-1675.